Comparative performance of different warfarin pharmacogenetic algorithms in Chinese patients

被引：0
|
作者：
Lou, Ying
Liu, Hong
Han, Lulu
Huang, Yiling
Li, Yishi
机构：
[1] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China
[2] Peking Union Med Coll, Beijing 100021, Peoples R China
来源：
CARDIOLOGY | 2013年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：139 / 139
页数：1
相关论文
共 50 条
  • [21] Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients
    Joyce H. S. You
    Raymond S. M. Wong
    Mary M. Y. Waye
    Yawei Mu
    Cadmon K. Lim
    Kai-chow Choi
    Gregory Cheng
    [J]. Journal of Thrombosis and Thrombolysis, 2011, 31 : 113 - 118
  • [22] Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients
    You, Joyce H. S.
    Wong, Raymond S. M.
    Waye, Mary M. Y.
    Mu, Yawei
    Lim, Cadmon K.
    Choi, Kai-chow
    Cheng, Gregory
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (01) : 113 - 118
  • [23] Estimation of the warfarin dose with a pharmacogenetic refinement algorithm in Chinese patients mainly under low-intensity warfarin anticoagulation
    Xu, Qiang
    Xu, Bin
    Zhang, Yuxiao
    Yang, Jie
    Gao, Lei
    Zhang, Yan
    Wang, Hongjuan
    Lu, Caiyi
    Zhao, Yusheng
    Yin, Tong
    [J]. THROMBOSIS AND HAEMOSTASIS, 2012, 108 (06) : 1132 - 1140
  • [24] Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohort
    Shin, Jaekyu
    Cao, Diana
    [J]. PHARMACOGENOMICS, 2011, 12 (01) : 125 - 134
  • [25] Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database
    Liu, Rong
    Li, Xi
    Zhang, Wei
    Zhou, Hong-Hao
    [J]. PLOS ONE, 2015, 10 (08):
  • [26] Pharmacogenetic dosing of warfarin in the Han-Chinese population: a randomized trial
    Wen, Ming-Shien
    Chang, Kuan-Cheng
    Lee, Tsong-Hai
    Chen, Ying-Fu
    Hung, Kuo-Chun
    Chang, Yeu-Jhy
    Liou, Chia-Wei
    Chen, Jin-Jer
    Chang, Chien-Hung
    Wang, Chao-Yung
    Jeng, Jiann-Shing
    Chuang, Hui-Ping
    Chen, Ying-Ting
    Chen, Chien-Hsiun
    Wu, Jer-Yuarn
    Chen, Yuan-Tsong
    Lee, Ming Ta Michael
    [J]. PHARMACOGENOMICS, 2017, 18 (03) : 245 - 253
  • [27] Implications of Pharmacogenetic Testing for Patients Taking Warfarin or Clopidogrel
    Megan M. Donohue
    David L. Tirschwell
    [J]. Current Neurology and Neuroscience Reports, 2011, 11 : 52 - 60
  • [28] Chinese Patients With Heart Valve Replacement Do Not Benefit From Warfarin Pharmacogenetic Testing on Anticoagulation Outcomes
    Hao, Yexia
    Yang, Jun
    Zheng, Xuan
    Hu, Yuanping
    Yan, Xinsheng
    Zhang, Litao
    [J]. THERAPEUTIC DRUG MONITORING, 2019, 41 (06) : 748 - 754
  • [29] Implications of Pharmacogenetic Testing for Patients Taking Warfarin or Clopidogrel
    Donohue, Megan M.
    Tirschwell, David L.
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (01) : 52 - 60
  • [30] Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population
    Lubitz, S. A.
    Scott, S. A.
    Rothlauf, E. B.
    Agarwal, A.
    Peter, I.
    Doheny, D.
    van der Zee, S.
    Jaremko, M.
    Yoo, C.
    Desnick, R. J.
    Halperin, J. L.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (05) : 1018 - 1026
12345